4//SEC Filing
Henderson Molly 4
Accession 0001209191-23-016023
CIK 0001783183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:03 PM ET
Size
6.1 KB
Accession
0001209191-23-016023
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2023-03-01$8.53/sh−2,032$17,335→ 76,015 total
Holdings
- 338.86(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
- [F2]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.3385 to $8.5524. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:03 PM ET
- Size
- 6.1 KB